This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 Nevertheless, the federal law and enforcement policy remained the same. million marijuana plants and conducted more than 6,600 marijuana related arrests.
As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform.
Despite its multi-year process of assessing potential exceptions from the Drug Preclusion and evaluating the safety and science of CBD, the FDA has not changed its prohibitive approach. However, the plain language of the Drug Preclusion, supporting case law ( see Pharmanex, Inc. SafetyData Matters. Shalala , 35 F.
Consumer products law blog. Class actions against CBD companies proliferate under federal and statelaw. Product testing and sampling protocols are not uniform across the country, and scientific data supporting the safety and efficacy of these products is under-developed.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
Data shows that commercial drivers are consuming cannabis more than any other drug, even if it can ruin their career. Commercial drivers test positive for cannabis more often these days than any other drug, according to the latest data from the U.S. But the FMCSA doesn’t care about statelaws. View original article.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
According to the Drug Policy Alliance , drug offenses are a leading cause of arrest in the United States. The FBI has shared data that arrests most often impact Black, Latinx, and Indigenous people and those with low incomes. One Redditor shares their concerns over the new ruling: I don’t really understand the logic.
Other CBD products, however, are still subject to various statelaw regulations as well as the U.S. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Decriminalization of Cannabis, Recognition of Statelaw Controlling Cannabis. Draft Bill Details. The Draft would also direct the Dep.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
Beyond Pesticides , October 8, 2019) As medicinal and recreational marijuana continue to be legalized in a growing number of states, concerns about the safety of the burgeoning industry—how the substance is grown, harvested, processed, distributed, sold, and used—have emerged. Here’s their blog post of 8 October.
The agency is called the California Cannabis Authority [yet another “CCA”] and here is the short version: The California Cannabis Authority is a Joint Powers Authority established by county governments to develop and manage a statewide data platform. The CCA’s By-Laws can be found here.
Navigating local, state, and federal regulations Although state-licensed cannabis labs are legal under statelaw, the federal government sees them in violation of federal law. states and four foreign countries. Lab-specific certifications are covered in the lab accreditation process below under ISO 17025.
FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under statelaw. Nonetheless, these products are widely available.
The study was published in The Journal of Drug Issues : Its full title is The spillover effect of recreational marijuana legalization on crime: Evidence from neighboring states of Colorado and Washington state. Our results from Colorado and Washington suggest that legalization has not had major detrimental effects on public safety.”
Leaf Data Systems Update. Please contact your WSLCB Enforcement Officer if you have any questions about implementation and enforcement of this important public safety rule. Leaf Data Systems Update. The next software release for Leaf Data Systems is coming soon! Paying Your Excise Tax. Full Newsletter. Release 1.37.5
Instead, adult-use dispensaries in the state are proving the system works by checking IDs as required by statelaw. The study , entitled “What is the likelihood that underage youth can obtain marijuana from licensed recreational marijuana outlets in California, a state where recreational marijuana is legal?”
There are consulting groups out there who have a track record of securing business licenses in a variety of states. The good ones are well-versed in the different statelaws and can guide companies through the process. Data & Software. Business data should be readily available and easily accessible at all times.
The state’s program has evolved to meet the needs of patients and the demands of the industry. Over time, Maryland has refined its approach to ensure the accessibility and safety of MMJ for its residents. The therapeutic potential of medical marijuana is backed by a growing body of research and clinical data.
Measure 109 was a breakthrough in statelaw, providing the nation’s first statutory framework for the supervised, adult use of psilocybin. Subsection 3(d) gives the agency power to require service center operators to meet public health and safety standards and industry best practices established by the agency.
Could doctors be punished by federal authorities for recommending marijuana to patients consistent with statelaw? Other issues arose at the intersection of novel drug laws and other statelaws. Cannabis reform states with no law school cannabis courses.
FDA states it has serious safety concerns with delta-8 THC. FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. FDA considers delta-8 THC to pose serious health and safety risks. meat, milk, and eggs). Moving Forward.
While the court declined to dismiss the action in its entirety (citing relevant statelaw that may still be considered on the merits), the court’s decision to stay—or postpone—the case under the primary jurisdiction doctrine, determined that FDA, and not the courts, should regulate CBD products, including what constitutes proper labeling.
However, approximately 37 states and the District of Columbia have passed laws with regard to legalised cannabis, which includes medical, recreational and decriminalised cannabis. There is no uniform set of statelaws for marketing legal cannabis at this time.
As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients.
We depend on a good relationship with law enforcement. She added, “Here, we are faced with the challenge of balancing public safety concerns like robberies, which the use of body cameras are intended to deter, with individual privacy.”. Public Health and Safety.
The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. COAs are generally issued by accredited laboratories and many states require sellers to include COAs with each cannabis or CBD product. Some states require all product labels to have custom QR codes that link to a COA.
Ability to meet the overall health needs of qualified patients and safety of the public. Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C.
Edibles must be tightly dosed, extracts must be extremely pure and flower has to be clean in order to be legally sold in the state. While this does add more costs, it also ensures safety for users, which has to be a good thing. These ensure even better protection for users when buying cannabis products in the state.
Ability to meet the overall health needs of qualified patients and safety of the public. Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C.
On Tuesday July 23, 2019, the United States Senate Committee on Banking, Housing, and Urban Affairs hosted a hearing to discuss national safety implications relating to federal regulations that force cannabis businesses to operate on a cash basis. By: Nabil Rodriguez, Esq. & & Victor Fox*.
The CDC promoted a policy that prohibits employees from using marijuana while on the job but recognized that a zero-tolerance policy for marijuana use may not be possible, depending on the relevant statelaw. A town has the option to later opt back in; however, the state will be issuing a limited number of dispensary licenses.
Even the federal government is beginning to change course: Early this year, President Obama predicted that if enough states decriminalize marijuana, Congress might remove it from the list of Schedule I drugs, and he has informed officials in Washington and Colorado that the Justice Department will not prosecute anyone who complies with statelaws.
Yet, in order to market a business’s commitment to consumer safety and environmental integrity, these values need to be communicated—but how?” And while processors, cultivators and dispensaries are disposing of waste correctly per statelaws, much of that waste just ends up in landfills.”
But consumers who buy products in this unregulated CBD market have no access to data showing the actual CBD and THC content of these products and have no way to determine whether these products are free of adulterants. . Testing and Labeling. Hemp manufacturers must meet all the following testing requirements: . (a)
Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Five of them used an age verification form , which is in compliance with the FDA age requirements and statelaws, where the customer has to upload a photo of a government ID, and the other required a signature on delivery of the package.
And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . While THC-O products like vape carts and tinctures are available for purchase online, both their legal status and their safety remain unproven. . What is THC-O?
Based on data as at August 31, 2021. Subject to compliance with all applicable US federal and statelaws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5
However, if looking at how current statelaws are progressing, this might change. Currently, most states have legalized marijuana, even recreationally. If this is the trend of local laws, then Delta-8 might actually be legal for medical use at the very least.
RS: It ‘s interesting, most people when they talk about the holdups to legalization, they talk about people aren’t ready or there’s not enough data or all of these things. And so, if they ‘re not pushing, the legislators are certainly not going to do anything on their own.
To date, it’s truly been “buyer beware” outside of states putting together their own protocols on things like recalls, packaging and labeling safety standards, quality assurance reviews, and testing. CBD testing, packaging, and labeling is no consumer safety picnic either.
All of those clients have to deal with a myriad of healthcare law and regulatory issues under both federal and statelaw, and the cost of compliance is not cheap. A team of CDER physicians, statisticians, chemists, pharmacologists, and other scientists reviews the company’s data and proposed labeling.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content